The Evolving Role of Cytokine-Based Therapy in Patients With Melanoma Progression and/or Drug Resistance

Download All
Learn how experts incorporate the newest cytokine-based approaches into optimal management of patients with melanoma with an on-demand Webinar plus an expert commentary and a downloadable slideset.
Ahmad Tarhini, MD, PhD
Program Director
person default
Elizabeth Buchbinder, MD
person default
George Ebanks, RN, BSN, OCN
person default
Jennifer Swank, PharmD, BCOP
Ahmad Tarhini, MD, PhD

ClinicalThought

In this commentary, an expert explains how high-dose IL-2 continues to have a role in the management of resistant or progressive melanoma and discusses evolving ways to incorporate IL-2 therapy into melanoma care.

person default Elizabeth Buchbinder, MD Released: February 15, 2021

Downloadable Slidesets

This downloadable slideset from an ondemand webcast provides an overview of the current treatment landscape in advanced melanoma including evidence on targeted therapy, immunotherapy, and combinations.

Ahmad Tarhini, MD, PhD Released: April 2, 2021

This downloadable slideset from an ondemand webcast offers insight into best practices for the management of adverse events associated with different classes of agents used for advanced melanoma including targeted therapy, immunotherapy, and high-dose IL2 therapy.

person default George Ebanks, RN, BSN, OCN person default Jennifer Swank, PharmD, BCOP Released: April 2, 2021

This downloadable slideset from an ondemand webcast explores the role of cytokine therapy and emerging strategies in the management of resistant or progressive melanoma. 

Ahmad Tarhini, MD, PhD Released: April 2, 2021

Download this summary slideset with a brief review the current treatment landscape in advanced melanoma and the role of cytokine-based therapy in progressive or resistant melanoma.

person default George Ebanks, RN, BSN, OCN person default Jennifer Swank, PharmD, BCOP Ahmad Tarhini, MD, PhD Released: April 2, 2021

On-Demand Webcast

Learn how experts leverage cytokine therapy for optimal treatment of patients with advanced melanoma in this on-demand webcast capturing a live CCO webinar.

Ahmad Tarhini, MD, PhD
Program Director
person default George Ebanks, RN, BSN, OCN person default Jennifer Swank, PharmD, BCOP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: April 8, 2021 Expired: April 7, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Clinigen Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue